GlassScriptPhysician profile
Noah Haroian
NPI 1710334594
$16,607.38
in general payments reported to CMS, 2019-2025
14 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.75 · 2020: $481 · 2021: $541 · 2022: $433 · 2023: $14K · 2024: $1,247 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $11K · Food and Beverage: $2,882 · Travel and Lodging: $1,750 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,500.00 |
| Food and Beverage | $2,882.34 |
| Travel and Lodging | $1,750.37 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $12,834.72 | 2023-2025 | Corevalve Evolut R |
| Abbott Laboratories | $2,369.78 | 2020-2024 | Mitraclip, Pressurewire, Coroflow |
| Edwards Lifesciences Corporation | $741.76 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amgen INC. | $168.13 | 2020-2023 | Repatha |
| Pfizer INC. | $142.23 | 2022-2023 | |
| Daiichi Sankyo INC. | $101.49 | 2022-2023 | Injectafer |
| Alnylam Pharmaceuticals INC. | $69.27 | 2022-2023 | Onpattro |
| Kiniksa Pharmaceuticals, LTD. | $50.83 | 2023 | Arcalyst |
| Boston Scientific Corporation | $39.38 | 2023 | Rotablator Rotational Atherectomy System Console Kit |
| Novo Nordisk INC | $21.54 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.09 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $17.75 | 2019 | |
| Shockwave Medical, INC | $17.40 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.01 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noah Haroian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.